Popular Posts

Friday, 1 March 2019

Walk in interview@ Hetero biopharma for multiple positions apply now

As a part of the Hetero Group, our Biologics vertical, comes with a rich legacy - Proven capabilities in the development, manufacturing and marketing of chemical intermediates, APIs, ARVs and Finished Dosage Formulations.
With leadership in chemical therapeutics, Hetero continues to lead from the front in the development and manufacturing of Biopharmaceuticals using novel technologies.
Hetero has 33 state-of-the-art manufacturing facilities strategically located worldwide. And a majority of our facilities have been successfully audited and approved by stringent regulatory authorities like US FDA, EU, TGA-Australia, MCC-South Africa and others. Our portfolio includes 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology and Immunology etc.